|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.8 USD | +2.54% |
|
+3.25% | +6.12% |
| Apr. 25 | Transcript : Core Laboratories Inc., Q1 2024 Earnings Call, Apr 25, 2024 | |
| Apr. 24 | Earnings Flash (CLB) CORE LABORATORIES Reports Q1 Revenue $129.6M, vs. Street Est of $124.5M | MT |
Core Laboratories N.V. provided earnings guidance for the first quarter of 2022. Core anticipates typical seasonal effects to impact the first quarter of 2022, with first quarter revenue down low to mid-single digits, sequentially. Core projects first quarter 2022 revenue to range from $117,000,000 to $122,000,000 and operating income of $11,900,000 to $14,000,000, yielding operating margins of approximately 11%.
EPS for the first quarter of 2022 is expected to be approximately $0.16 to $0.20.
| 1st Jan change | Capi. | |
|---|---|---|
| +6.12% | 860M | |
| +12.08% | 16.8B | |
| 0.00% | 7.6B | |
| -15.42% | 2.87B | |
| -10.43% | 2.73B | |
| -28.62% | 1.81B | |
| -4.86% | 1.17B | |
| -7.70% | 1.07B | |
| -13.21% | 829M | |
| -22.52% | 733M |
CORE LABORATORIES INC. 
